| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 46, 756-765, Copyright © 1978 by Endocrine Society
ARTICLES |
RW Gray, AE Caldas, DR Wilz, J Lemann Jr, GA Smith and HF DeLuca
The synthesis of very high specific activity 25-OH-vitamin D3 (78 Ci/mmol) has made possible the study of the metabolism and plasma disappearance of 3H after a single dose of 3H-1,25-(OH)2-D3 in quantities that are only 10-20% of the endogenous plasma pool. We studied seven healthy adults who were given doses of 1,25-(OH)2-D3 ranging from 30-2300 pmol. Plasma disappearance was rapid with only 14 +/- 2% of administered 3H remaining in the plasma pool 4 h after labeling. Plasma metabolite profiles during the first 4 h showed only 1,25-(OH)2-D3. Thereafter, significant amounts of other metabolites were detected. The 6-day cumulative excretion of 3H in urine and feces (virtually all associated with metabolites of 1,25-(OH)2-D3) averaged 16 +/- 3% and 49 +/- 11% of the dose, respectively. Compartmental analysis of the isotope data for two subjects who received the smallest doses of 1,25-(OH)2-D3 indicated that endogenous renal 1,25-(OH)2-D3 synthesis rates approximate 0.8-2.4 nmol/day (0.3-1.0 microgram/day).
This article has been cited by other articles:
![]() |
J. E Zerwekh Blood biomarkers of vitamin D status Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1087S - 1091S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Young, G. G. Schwartz, L. Wang, D. P. Jamieson, L. W. Whitlatch, J. N. Flanagan, B. L. Lokeshwar, M. F. Holick, and T. C. Chen The prostate 25-hydroxyvitamin D-1{alpha}-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D Carcinogenesis, June 1, 2004; 25(6): 967 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Tryfonidou, M. A. Oosterlaken-Dijksterhuis, J. A. Mol, T. S. G. A. M. van den Ingh, W. E. van den Brom, and H. A. W. Hazewinkel 24-Hydroxylase: potential key regulator in hypervitaminosis D3 in growing dogs Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E505 - E513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Tryfonidou, J. J. Stevenhagen, G.J.C.M. van den Bemd, M. A. Oosterlaken-Dijksterhuis, H. F. DeLuca, J. A. Mol, W. E. van den Brom, J.P.T.M. van Leeuwen, and H.A.W. Hazewinkel Moderate Cholecalciferol Supplementation Depresses Intestinal Calcium Absorption in Growing Dogs J. Nutr., September 1, 2002; 132(9): 2644 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA Current Understanding of the Molecular Actions of Vitamin D Physiol Rev, October 1, 1998; 78(4): 1193 - 1231. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |